<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>MATHEMATICAL MODELING OF MOLECULAR TRANSMEMBRANE TRANSPORT AND CHANGES OF TISSUES´ DIELECTRIC PROPERTIES DUE TO ELECTROPORATION</dc:title><dc:creator>DERMOL-ČERNE,	JANJA	(Avtor)
	</dc:creator><dc:creator>Miklavčič,	Damijan	(Mentor)
	</dc:creator><dc:creator>Serša,	Gregor	(Komentor)
	</dc:creator><dc:subject>Electroporation</dc:subject><dc:subject>multiscale modeling</dc:subject><dc:subject>excitable cells</dc:subject><dc:subject>predictive models</dc:subject><dc:subject>electrochemotherapy</dc:subject><dc:subject>numerical modeling</dc:subject><dc:subject>irreversible electroporation</dc:subject><dc:description>Electroporation is a phenomenon, which occurs when short high voltage pulses are applied to cells and tissues
resulting in a transient increase in membrane permeability or cell death, presumably due to pore formation. If
cells recover after pulse application, this is reversible electroporation. If cells die, this is irreversible
electroporation. Electroporation is used in biotechnology for biocompound extraction and cryopreservation, in
food processing for sterilization and pasteurization of liquid food and in medicine for treating tumors by
electrochemotherapy or irreversible electroporation as an ablation technique, for gene electrotransfer,
transdermal drug delivery, DNA vaccination, and cell fusion.
In electroporation-based medical treatments, we can treat tumors with predefined electrode geometry and
parameters of electric pulses. When we treat larger tumors of irregular shape treatment plan of the position of the
electrodes and parameters of the electric pulses has to be calculated before each treatment to assure coverage of
the tumor with a sufficient electric field. In treatment plans, currently, 1) we assume that above an
experimentally determined critical electric field all cells are affected and below not, although, in reality, the
transition between non-electroporated and electroporated state is continuous. 2) We do not take into account the
excitability of some tissues. 3) The increase in tissues’ conductivity is described phenomenologically and does
not include mechanisms of electroporation. 4) Transport of chemotherapeutics into the tumor cells in
electrochemotherapy treatments is not included in the treatment plan although it is vital for a successful
treatment. We focused on the mathematical and numerical models of electroporation with the aim of including
them in the treatment planning of electroporation-based medical treatments.
We aimed to model processes happening during electroporation of tissues, relevant in the clinical procedures, by
taking into account processes happening at the single cell level. First, we used mathematical models of cell
membrane permeability and cell death which are phenomenological descriptions of experimental data. The
models were chosen on the basis of the best fit with the experimental data. However, they did not include
mechanisms of electroporation, and their transferability to tissues was questionable. We modeled time dynamics
of dye uptake due to increased cell membrane permeability in several electroporation buffers with regard to the
electrosensitization, i.e., delayed hypersensitivity to electric pulses caused by pretreating cells with electric
pulses. We also modeled the strength-duration depolarization curve and cell membrane permeability curve of
excitable and non-excitable cell lines which could be used to optimize pulse parameters to achieve maximal drug
uptake at minimal tissue excitation.
Second, we modeled change in dielectric properties of tissues during electroporation. Model of change in
dielectric properties of tissues was built for skin and validated with current-voltage measurements. Dielectric
properties of separate layers of skin before electroporation were determined by taking into account geometric
and dielectric properties of single cells, i.e., keratinocytes, corneocytes. Dielectric properties of separate layers
during electroporation were obtained from cell-level models of pore formation on single cells of lower skin
layers (keratinocytes in epidermis and lipid spheres in papillary dermis) and local transport region formation in
the stratum corneum. Current-voltage measurements of long low-voltage pulses were accurately described taking
into account local transport region formation, pore formation in the cells of lower layers and electrode
polarization. Voltage measurements of short high-voltage pulses were also accurately described in a similar way
as with long low-voltage pulses; however, the model underestimated the current, probably due to
electrochemical reactions taking place at the electrode-electrolyte interface.
Third, we modeled the transport of chemotherapeutics during electrochemotherapy in vivo. In
electrochemotherapy treatments, transport of chemotherapeutics in sufficient amounts into the cell is vital for a
successful treatment. We performed experiments in vitro and measured the intracellular platinum mass as a
function of pulse number and electric field by inductively coupled plasma – mass spectrometry. Using the dualporosity
model, we calculated the in vitro permeability coefficient as a function of electric field and number of
applied pulses. The in vitro determined permeability coefficient was then used in the numerical model of mouse
melanoma tumor to describe the transport of cisplatin to the tumor cells. We took into account the differences in
the transport of cisplatin in vitro and in vivo caused by the decreased mobility of molecules and decreased
membrane area available for the uptake in vivo due to the high volume fraction of cells, the presence of cell
matrix and close cell connections. Our model accurately described the experimental results obtained in
electrochemotherapy of tumors and could be used to predict the efficiency of electrochemotherapy in vitro thus
reducing the number of needed animal experiments.
In the thesis, we connected the models at the cell level to the models at the tissue level with respect to cell
membrane permeability and depolarization, cell death, change in dielectric properties and transport.
Our models
offer a step forward in modeling and understanding electroporation at the tissue level. In future, our models
could be used to improve treatment planning of electroporation-based medical treatments.</dc:description><dc:date>2018</dc:date><dc:date>2018-05-18 11:02:29</dc:date><dc:type>Doktorsko delo/naloga</dc:type><dc:identifier>101263</dc:identifier><dc:identifier>VisID: 41881</dc:identifier><dc:language>sl</dc:language></metadata>
